Literature DB >> 27486031

Diagnostic accuracy of individual antenatal tools for prediction of small-for-gestational age at birth.

B Poljak1, U Agarwal2, R Jackson3, Z Alfirevic1, A Sharp1.   

Abstract

OBJECTIVE: To determine the accuracy of fetal and newborn growth charts for the prediction of small-for-gestational age (SGA) at birth (birth weight < 10th centile).
METHODS: This was a prospective cohort study performed within a UK specialist fetal growth clinic. A total of 105 consecutive pregnant women referred for a suspected SGA fetus were included. All pregnancies were managed according to a standard protocol using estimated fetal weight (EFW) plotted on customized Gestation Related Optimal Weight (GROW) charts. The last antenatal estimates of EFW (according to charts of GROW, Hadlock et al. and Mikolajczyk et al.), abdominal circumference (AC) (according to charts of Hadlock et al., INTERGROWTH-21st Project and Chitty et al.) or change in AC over time (calculated according to Pregnancy Outcome Prediction (POP) study) were compared against four birth-weight charts (GROW, INTERGROWTH-21st , Mikolajczyk et al. and World Health Organization (WHO)). The ability of each antenatal test to predict adverse perinatal outcome (APO) was assessed.
RESULTS: Birth weight < 10th centile was assigned in 62 (59%) neonates using the GROW chart, 57 (54%) using the Mikolajczyk et al. chart, 55 (52%) using the INTERGROWTH-21st chart and 51 (49%) using the WHO chart. AC-Hadlock had the best negative likelihood ratio (range, 0.3-0.4) and sensitivity (range, 74%-82%) for predicting SGA as defined by all four postnatal birth-weight charts. AC-INTERGROWTH-21st had the best positive likelihood ratio (range, 5.9-10.9) and specificity (94%-96%). For prediction of APO, AC-Hadlock and EFW-GROW had the best sensitivities (57% and 52%, respectively), whereas AC-POP had the best positive likelihood ratio (2.2) and specificity (88%). Antenatal prediction of APO increased to a sensitivity of 61% when AC-POP and EFW-GROW were combined; however, specificity was only 56%.
CONCLUSIONS: We have identified wide variation in the diagnostic accuracy of various antenatal tools for the prediction of both SGA and APO, dependent on the choice of chart. Suboptimal diagnostic accuracy of commonly used antenatal tests may lead to increasing medicalization without prevention of APO. Researchers should focus their attention on a combination of fetal biometry and biomarkers for better prediction of SGA and prevention of APO.
Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  fetal growth restriction; small-for-gestational age; ultrasound prediction

Mesh:

Year:  2017        PMID: 27486031     DOI: 10.1002/uog.17211

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  6 in total

1.  In vivo placental MRI shape and textural features predict fetal growth restriction and postnatal outcome.

Authors:  Sonia Dahdouh; Nickie Andescavage; Sayali Yewale; Alexa Yarish; Diane Lanham; Dorothy Bulas; Adre J du Plessis; Catherine Limperopoulos
Journal:  J Magn Reson Imaging       Date:  2017-07-22       Impact factor: 4.813

Review 2.  Individualized growth assessment: conceptual framework and practical implementation for the evaluation of fetal growth and neonatal growth outcome.

Authors:  Russell L Deter; Wesley Lee; Lami Yeo; Offer Erez; Uma Ramamurthy; Medha Naik; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2018-02       Impact factor: 8.661

3.  IUGR Is Associated With Marked Hyperphosphorylation of Decidual and Maternal Plasma IGFBP-1.

Authors:  Madhulika B Gupta; Majida Abu Shehab; Karen Nygard; Kyle Biggar; Sahil S Singal; Nanette Santoro; Theresa L Powell; Thomas Jansson
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

4.  In vivo assessment of placental and brain volumes in growth-restricted fetuses with and without fetal Doppler changes using quantitative 3D MRI.

Authors:  N Andescavage; A duPlessis; M Metzler; D Bulas; G Vezina; M Jacobs; S N Iqbal; A Baschat; C Limperopoulos
Journal:  J Perinatol       Date:  2017-08-24       Impact factor: 2.521

5.  The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32 + 0 weeks' gestation.

Authors:  Joanna Gent; Sian Bullough; Jane Harrold; Richard Jackson; Kerry Woolfall; Lazaros Andronis; Louise Kenny; Christine Cornforth; Alexander E P Heazell; Emily Benbow; Zarko Alfirevic; Andrew Sharp
Journal:  Pilot Feasibility Stud       Date:  2020-11-19

6.  Swedish intrauterine growth reference ranges for estimated fetal weight.

Authors:  Linda Lindström; Mårten Ageheim; Ove Axelsson; Laith Hussain-Alkhateeb; Alkistis Skalkidou; Anna-Karin Wikström; Eva Bergman
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.